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Abstract
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the aetiologic agent of enzootic 
pneumonia in swine, a prevalent chronic respiratory disease worldwide. Mycoplasma 
hyopneumoniae is a small, self‐replicating microorganism that possesses several char‐
acteristics allowing for limited biosynthetic abilities, resulting in the fastidious, host‐
specific growth and unique pathogenic properties of this microorganism. Variation 
across several isolates of M. hyopneumoniae has been described at antigenic, prot‐
eomic, transcriptomic, pathogenic and genomic levels. The microorganism possesses 
a minimal number of genes that regulate the transcription process. Post‐translational 
modifications (PTM) occur frequently in a wide range of functional proteins. The PTM 
by which M. hyopneumoniae regulates its surface topography could play key roles in 
cell adhesion, evasion and/or modulation of the host immune system. The clinical 
outcome of M. hyopneumoniae infections is determined by different factors, such as 
housing conditions, management practices, co‐infections and also by virulence dif‐
ferences among M. hyopneumoniae isolates. Factors contributing to adherence and 
colonization as well as the capacity to modulate inflammatory and immune responses 
might be crucial. Different components of the cell membrane (i.e. proteins, glycopro‐
teins and lipoproteins) may serve as adhesins and/or be toxic for the respiratory tract 
cells. Mechanisms leading to virulence are complex and more research is needed to 
identify markers for virulence. The utilization of typing methods and complete or 
partial‐gene sequencing for M. hyopneumoniae characterization has increased in di‐
agnostic laboratories as control and elimination strategies for this microorganism are 
attempted worldwide. A commonly employed molecular typing method for M. hyo‐
pneumoniae is Multiple‐Locus Variable number tandem repeat Analysis (MLVA). The 
agreement of a shared terminology and classification for the various techniques, spe‐
cifically MLVA, has not been described, which makes inferences across the literature 
unsuitable. Therefore, molecular trends for M. hyopneumoniae have been outlined 
and a common terminology and classification based on Variable Number Tandem 
Repeats (VNTR) types has been proposed.
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1  | INTRODUC TION
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the aetiologic 
agent of enzootic pneumonia (EP) in swine (Goodwin, Pomeroy, 
& Whittlestone, 1965; Maré & Switzer, 1965), a worldwide preva‐
lent, chronic respiratory disease (Maes et al., 2018). Similar to other 
mycoplasmas, M. hyopneumoniae is a small, self‐replicating micro‐
organism that possesses several characteristics allowing for lim‐
ited biosynthetic abilities, resulting in the fastidious, host‐specific 
growth and unique pathogenic properties of this microorganism 
(Razin, Yogev, & Naot, 1998). The pathogenesis of M. hyopneumoniae 
is complex and not yet fully elucidated. It is perceived that the level 
of colonization and initial development of EP depend on the ability 
of M. hyopneumoniae to adhere to ciliated epithelium within respira‐
tory airways, which is mediated through receptor‐ligand interactions 
and surface adhesion proteins (Minion, Adams, & Hsu, 2000; Ross, 
1999). Once adherence occurs, the epithelium becomes deciliated 
and bronchial epithelial and goblet cells are lost, leading to the im‐
pairment of the mucociliary tract apparatus and the invasion of sec‐
ondary respiratory pathogens to induce disease (Debey, Jacobson, 
& Ross, 1992; Thacker & Minion, 2012). The development of EP is 
assumed to occur from antigenic variation (de Castro et al., 2006; 
Wise, 1993), influx of pro‐inflammatory cytokines to the site of in‐
fection due to alteration in the host immune response (Rodriguez, 
Ramirez, Sarradell, Andrada, & Lorenzo, 2004; Thacker, Thacker, 
Kuhn, Hawkins, & Waters, 2000) and potentially the formation of 
biofilms in the airways (Raymond, Jenkins, Turnbull, Whitchurch, & 
Djordjevic, 2018). Clinical signs suggestive of M. hyopneumoniae in‐
fection consist of dry cough, laboured breathing and reduced growth 
rate (Thacker & Minion, 2012), which usually occur after 6–8 weeks 
post‐exposure (Sibila et al., 2009). Economical losses result from the 
clinical manifestations of EP and the increased costs of prevention 
and eradication, that are implemented to combat further disease and 
occurrence of secondary bacterial pathogens infections (Maes et al., 
2018; Pointon, Byrt, & Heap, 1985; Straw, Shin, & Yeager, 1990). 
Control strategies for M. hyopneumoniae, including antimicrobials, 
vaccines and management practices, have been employed to reduce 
the economic losses derived from the clinical manifestations of EP 
(Garza‐Moreno, Segalés, Pieters, Romagosa, & Sibila, 2018; Maes et 
al., 2018; Pieters & Fano, 2016).
Several laboratory techniques have been utilized to character‐
ize M. hyopneumoniae and have shown differences at antigenic, pro‐
teomic, transcriptomic, pathogenic and genomic levels (Assunção, 
Fe, Ramírez, González Llamazares, & Poveda, 2005; Calus et al., 
2007; Minion et al., 2004). Understanding M. hyopneumoniae at the 
molecular level would eventually aid in the advancement of disease 
control strategies. However, discrepancies regarding the molecular 
characterization of M. hyopneumoniae are present across the liter‐
ature and inferences based on such information can be challenging 
to agree upon. Common methods for genomic classification and in‐
terpretation would provide clarity on disease and outbreak investi‐
gations for this microorganism. Therefore, this review article aims 
to summarize published information on M. hyopneumoniae variability 
at the antigenic, proteomic, transcriptomic, pathogenic and genomic 
levels, while highlighting methods employed for the characteriza‐
tion and classification at the genomic level, proposing commonality 
among investigations.
2  | MYCOPL A SMA HYOPN EUMON IAE  
VARIABILIT Y
Mycoplasma species have been suggested to have phylogenetically 
evolved from gram‐positive, walled eubacteria, allowing for unique, 
taxonomic characteristics (Maniloff, 1983; Razin, 1985; Rocha & 
Blanchard, 2002). Studies have demonstrated the ability of M. hyo‐
pneumoniae to undergo phenotypic switching, antigenic variation 
and proteome alterations that may contribute to the versatility and 
variations between host‐pathogen interactions (Assunção et al., 
2005; Calus et al., 2007; Minion et al., 2004). Variability has been 
demonstrated across several M. hyopneumoniae strains and isolates 
at the antigenic, proteomic, transcriptomic, pathogenic and genomic 
level. For the purpose of this review, the difference between a bac‐
terial strain and an isolate is that the former has been characterized 
(classified and/or identified) and the latter has been obtained from 
single colony cloning using pure culture.
2.1 | Antigenic variability
Antigenic variability is described as the ability of a microorganism 
to alter its surface components (i.e. flagella, microvilli and/or mem‐
brane proteins, among others), causing differences in the host im‐
mune response against those structures (Razin et al., 1998). Among 
M. hyopneumoniae strains, antigenic variability has been evaluated 
in several studies using different serologic and proteomic assays, 
such as immunoblotting and two‐dimensional gel electrophoresis 
(Assunção et al., 2005; Ro & Ross, 1983; Scarman, Chin, Eamens, 
Delaney, & Djordjevic, 1997). The techniques used, antigenic pro‐
teins identified and the most relevant findings of each study are 
summarized in Table 1.
Mycoplasma hyopneumoniae has a relatively small number of 
proteins with identified antigenic properties (Table 1), including 
cytosolic (i.e. P36), membrane (i.e. P44, P46, P50, P65, P70, P74 
and P76, among others) or adhesion proteins (i.e. P97). The cyto‐
solic protein P36, named lactate dehydrogenase (LDH; Haldimann, 
Nicolet, & Frey, 1993), was detected in 13 M. hyopneumoniae field 
strains from Switzerland, Hungary, France and Canada (Stipkovits, 
Nicolet, Haldimann, & Frey, 1991). In contrast, a subsequent report 
concluded that this protein was not detected in the 18 studied M. 
hyopneumoniae field strains from Spain (Assunção et al., 2005). 
However, it remains unknown whether this lack of detection is the 
result of a true absence or is derived from the lack of expression due 
to unfavourable culture conditions, as previously described for other 
bacteria such as Escherichia coli (Jiang, Nikolova, & Clarck, 2001) or 
a detection failure due to substantial sequence variability between 
different M. hyopneumoniae strains.
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Information regarding membrane protein immunoreactivity is 
scarce. For example, P46 was identified in all tested strains (Assunção 
et al., 2005) and it was considered useful for the development of an 
ELISA test for M. hyopneumoniae antibody monitoring (Okada et al., 
2005). Another membrane protein (P74) with well‐known antigenic 
properties is currently used as antigen for a commercial ELISA test 
to detect antibodies against the pathogen (Bereiter, Young, Joo, & 
Ross, 1990). In addition, P44, P50, P65 and P70 are also membrane 
proteins that confer different proteolytic epitope maps (Wise & Kim, 
1987a, 1987b). Similarly, the antigenic variability of adhesins such as 
P97, involved in the adherence of M. hyopneumoniae to the cilia, was 
detected in all studied strains (Assunção et al., 2005; Zhang, Young, 
Ross, Zhang, & Young, 1995).
Differences in antigenic profiles have been related to the vari‐
ation in the size (Assunção et al., 2005; Wise & Kim, 1987b; Zhang 
et al., 1995), the expression of the proteins (Razin et al., 1998; 
Rosengarten & Yogev, 1996) and adaptation mechanisms of M. hy‐
opneumoniae against environmental changes, e.g. culture passages 
(Assunção et al., 2005; Razin et al., 1998). Such variability has 
been proposed as a pathogenic mechanism to evade the porcine 
TA B L E  1   Summary of literature assessing the antigenic variability of Mycoplasma hyopneumoniae
Method Specimen and sample type Most relevant findings Reference
Immunoblot using hy‐
perimmune antisera 
Two‐Dimensional gel 
electrophoresis
M. hyopneumoniae field strains 
M. hyopneumoniae reference 
strains (11 and J) 
M. flocculare field strains 
M. hyorhinis field strains
Variability in antigenic structure of M. hyopneumoniae 
strains 
M. hyopneumoniae strains were antigenically similar and 
close to M. flocculare
Ro and Ross (1983)
Immunoblot assay M. hyopneumoniae isolate Identification of surface proteins:
P65, P50, P44: hydrophobic integral membrane proteins
P41: hydrophilic extrinsic protein
P65 and P44 were identified as immunodominant antigens 
in the host
Wise and Kim (1987a)
Immunoblot assay M. hyopneumoniae reference 
strains (11 and J) 
M. flocculare reference strain 
(ATCC 2399)
P65, P50, P44: highly immunogenic 
Intraspecies size variant of P70 
Intraspecies binding failure of P82
Wise and Kim (1987b)
Immunoblot using 
anti‐P36 antibodies
M. hyopneumoniae field strains 
M. hyopneumoniae reference 
strain (J) 
Other species tested: M. 
flocculare, M. hyorhinis, M. 
hyosynoviae, A. axanthum, A. 
laidlawii, A. granularum
Identification of 36 kDa protein (P36) as common M. hyo‐
pneumoniae antigen in all strains 
No detection of P36 in other Mycoplasma spp. or 
Acholeplasma spp. tested
Stipkovits et al. (1991)
Immunoblot assay M. hyopneumoniae field strains 
(L127, 232 (2A3), 232 (FA1) 
144L) 
M. hyopneumoniae reference 
strain (J)
Identification of 97 kDa protein (P97) as adhesin of M. 
hyopneumoniae 
Intraspecies size variation of P97 
Intraspecies adherence capability variation
Zhang et al. (1995)
SDS‐ PAGE 
Immunoblot assay
M. hyopneumoniae field strains 
M. flocculare field strains 
M. hyorhinis field strains
Identification of 43 kDa protein (P43) reactive with M. 
hyopneumoniae but no with M. flocculare or M. hyorhinis. 
No differences between M. hyopneumoniae strains from 
diverse geographical regions
Scarman et al. (1997)
SDS‐ PAGE 
Immunoblot assay
M. hyopneumoniae field strains P46 was observed in all studied M. hyopneumoniae strains. 
Intraspecies size variant of P97 
Relation between antigenic characteristics variation and 
number of passages in culture
Assunção et al. (2005)
SDS‐ PAGE 
Immunoblot assay 
Mass spectrometry
M. hyopneumoniae strain (7,448) Identification of M. hyopneumoniae antigens:
Heat shock protein 70
Elongation factor Tu
Pyruvate dehydrogenase E1‐beta subunit
P76 membrane protein
Pinto, Chemale, et al. 
(2007) and Pinto, 
Oliveira de Carvalho, 
et al. (2007)
Immunoblot assay 
Protein microarray
M. hyopneumoniae field isolates 
M. flocculare field isolates 
M. hyorhinis field isolates 
M. hyosynoviae field isolates
Extensive cross‐reactivity between M. hyopneumoniae and 
M. flocculare isolates 
Identification of 3 M. hyopneumoniae proteins (mhp182, 
mhp638 and mhp684 [P146]) with non‐cross reactivity 
with other mycoplasmas
Petersen et al. (2016)
Note: Abbreviation: SDS‐PAGE: Sodium Dodecyl Sulfate‐Polyacrylamide Gel Electrophoresis.
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immune response (Zhang et al., 1995). Although Mycoplasma hy‐
opneumoniae antigenic diversity has been shown, a close rela‐
tionship of antigenic profiles between different strains has been 
described (Ro & Ross, 1983). In fact, comparable antigenic profiles 
(immunoreactivity against proteins of molecular weight from 36 
to 200 kDa) were detected in different M. hyopneumoniae strains 
from Australia, the United Kingdom and the United States using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‐
PAGE) as well as immunoblotting techniques (Scarman et al., 
1997). This information suggests that limited antigenic variability 
among several M. hyopneumoniae strains obtained from different 
geographical locations can also occur, proposing the presence of 
conserved antigens related to the survival of the species (Scarman 
et al., 1997).
Additionally, the existence of cross‐reactive antigens between 
M. hyopneumoniae and other swine mycoplasmas like M. hyorhinis, 
M. hyosynoviae and M. flocculare has been documented (Table 1). The 
closest antigenic relationship was described between M. hyopneu‐
moniae and M. flocculare strains (Petersen et al., 2016; Ro & Ross, 
1983). In fact, one recent study indicated that only three (mhp182, 
mhp638 and mhp684) out of 39 tested M. hyopneumoniae proteins 
were exclusively present in M. hyopneumoniae and did not cross‐
react with M. hyorhinis, M. hyosynoviae and M. flocculare (Petersen et 
al., 2016). Similarly, a 43 kDA protein was identified as reactive with 
M. hyopneumoniae but not with M. flocculare or M. hyorhinis (Scarman 
et al., 1997).
The M. hyopneumoniae antigenic variability described in the pre‐
viously mentioned studies may have several implications. Although 
the mechanisms of M. hyopneumoniae pathogenesis have not been 
fully elucidated, surface protein variation might play a crucial role in 
M. hyopneumoniae adhesion to the ciliated epithelium (Wise & Kim, 
1987b) and to evade the host immune system (Maes et al., 2018). 
Indeed, antigenic differences could modify the ability to induce 
immune responses among M. hyopneumoniae strains as it has been 
observed under experimental (Strait, Madsed, Minion, & Thacker, 
2003; Vicca et al., 2002) and natural conditions (Ameri, Zhou, & Hsu, 
2006). Likewise, it is still unclear whether putative antigenic varia‐
tions may imply differences in the antibody profiles generated by 
field strains when compared to those used in bacterins (Villarreal et 
al., 2012). Furthermore, the cross‐reactivity detected between M. 
hyopneumoniae and other swine mycoplasmas may interfere with 
the results of serological diagnostic methods (Assunção et al., 2005; 
Petersen et al., 2016; Rosengarten & Yogev, 1996). Therefore, these 
findings indicate the need to identify conserved M. hyopneumoniae 
antigens as targets to develop new vaccines against this bacterium, 
as well as highly accurate serological diagnostic tests.
2.2 | Proteomic and transcriptomic variability
Under adverse conditions, M. hyopneumoniae, like other bacteria, 
launches ‘stress responses’ that improve its chances of a successful 
adaptation to the challenges posed by unfavourable environments. 
Such adaptation is reflected in protein diversification by means of 
different mechanisms, thus allowing the microorganism to survive, 
colonize and cause disease.
One mechanism of protein diversification is gene expression reg‐
ulation. Several transcriptomic studies have aimed to identify differ‐
ences in gene expression, under different environmental conditions, 
such as heat shock (Madsen, Nettleton, Thacker, Edwards, & Minion, 
2006; Madsen, Nettleton, Thacker, & Minion, 2006), iron depriva‐
tion (Madsen, Nettleton, Thacker, Edwards, et al., 2006; Madsen, 
Nettleton, Thacker, & Minion, 2006), oxidative stress (Schafer, Oneal, 
Madsen, & Minion, 2007) and norepinephrine exposure (Oneal, 
Schafer, Madsen, & Minion, 2008). Most of the referenced studies 
agree that, in the face of adverse conditions, an increase in the regu‐
lation of metabolic related genes occurs, while there is an expression 
decrease in transcription and translation of related genes.
Using different approaches, high variability of total proteins 
among field and reference M. hyopneumoniae strains has been ob‐
served (Assunção et al., 2005; Calus et al., 2007; Pinto, Chemale, 
et al., 2007; Pinto, Klein, Zaha, & Ferreira, 2009; Pinto, Oliveira de 
Carvalho, Alves‐Junior, Brocchi, & Silveira Schrank, 2007). In fact, 
the analysis of the M. hyopneumoniae field isolates, obtained from 
several herds located in the same or different countries with various 
degrees of virulence, demonstrated high protein variability without 
relation to isolate source (Assunção et al., 2005; Calus et al., 2007). 
High protein heterogeneity has been already observed between 
pathogenic (i.e. 232 and 7,448) and non‐pathogenic (i.e. J) M. hyo‐
pneumoniae strains (Li et al., 2009; Pinto, Chemale, et al., 2007; Pinto 
et al., 2009; Pinto, Oliveira de Carvalho, et al., 2007). Moreover, Paes 
et al. (2017) compared the secretomes of M. hyopneumoniae strain 
7,448 and the commensal M. flocculare. They identified that a higher 
number of proteins were secreted by the virulent M. hyopneumoniae 
strain 7,448 (62) compared to M. flocculare (26). Overall, 15 viru‐
lence‐related proteins were identified in M. hyopneumoniae strain 
7,448 and only four in M. flocculare, of which two proteins were 
shared with M. hyopneumoniae. However, evidence suggests that 
protein variability is not necessarily related to virulence (Calus et al., 
2007; Pinto, Chemale, et al., 2007; Pinto et al., 2009; Pinto, Oliveira 
de Carvalho, et al., 2007). Pinto et al. (2009) showed differential ex‐
pression in approximately one‐third of the proteome between two 
strains of similar virulence. Furthermore, an overexpression of pro‐
teins related to heat shock and oxidative stress responses was ob‐
served in the pathogenic M. hyopneumoniae strains 7,448 and 7,422, 
compared to the non‐pathogenic M. hyopneumoniae strain J.
Mycoplasma hyopneumoniae possesses a minimal number of 
genes that regulate the transcription process (Vasconcelos et al., 
2005), thus, the regulation of post‐translational processes is rele‐
vant for this pathogen. Post‐translational modifications (PTM) occur 
frequently in a wide range of functional proteins of M. hyopneumo‐
niae (Tacchi et al., 2016). Endoproteolytic cleavage has been iden‐
tified in cell surface proteins as lipoproteins, multitasking proteins 
(Tacchi et al., 2016) and P97/P102 adhesins (Bogema et al., 2012, 
2011; Deutscher et al., 2010, 2012; Djordjevic, Cordwell, Djordjevic, 
Wilton, & Minion, 2004; Raymond et al., 2015, 2013; Seymour et al., 
2012; Tacchi et al., 2014; Wilton et al., 2009). The PTM by which M. 
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hyopneumoniae regulates its surface topography could play key roles 
in cell adhesion and evasion and/or modulation of the host immune 
system.
Finally, secreted proteins from both, swine respiratory cells and 
M. hyopneumoniae, play important roles between the host‐pathogen 
interaction. Mycoplasma hyopneumoniae strain 7,448 secretes higher 
number of adhesins and other proteins with known function than 
M. hyopneumoniae J strain and M. flocculare (Leal Zimmer, Paludo, 
Moura, Barr, & Ferreira, 2018; Paes et al., 2017), which may be re‐
lated to bacterial pathogenicity. On the other hand, swine tracheal 
cells showed different secretion profiles in response to infection 
with M. hyopneumoniae strains or with M. flocculare (Leal Zimmer 
et al., 2018). Some proteins secreted in response to cell injury and 
death, as Damage‐associated molecular patterns (DAMPs) proteins 
and extracellular proteasome proteins, have been detected only in 
swine cells infected with M. hyopneumoniae 7,448 (Leal Zimmer et 
al., 2018). These results suggest differences in the secretome com‐
position from M. hyopneumoniae according to the virulence of the 
strain.
2.3 | Pathogenic variability
The pathogenicity of an organism refers to its ability to cause disease 
or lesions to the host. Commensals and opportunistic pathogens lack 
this inherent ability. Virulence refers to the degree of disease or le‐
sion severity caused by the organism.
2.3.1 | Differences in virulence
The clinical outcome of M. hyopneumoniae infections is determined 
by different factors such as housing conditions, management prac‐
tices, infections with other pathogens and also by differences among 
M. hyopneumoniae strains.
Previous studies have shown that M. hyopneumoniae field isolates 
may induce different levels of disease and lesions upon infection. The 
first and most extensive study was conducted by Vicca et al. (2003) 
in which the virulence of six field isolates of M. hyopneumoniae was 
compared using challenge infections in conventional pigs followed 
by necropsy 4 weeks later (commonly accepted as the standard in‐
fection model). The isolates were classified as highly, moderately 
or low virulent based on severity of clinical signs and macroscopic 
and microscopic lung lesions produced. The virulence of some of 
these M. hyopneumoniae isolates was confirmed in subsequent stud‐
ies (Meyns et al., 2004; Villarreal et al., 2009, 2011). Woolley et al. 
(2012) also observed differences between two Australian M. hyo‐
pneumoniae field isolates (i.e. Hillcrest and Beaufort), with the first 
one being superior to experimentally induce more severe coughing 
and pneumonic lesions than the second isolate.
Although M. hyopneumoniae is primarily a respiratory pathogen, 
it has also been isolated (Le Carrou, Laurentie, Kobisch, & Gautier‐
Bouchardon, 2006; Marchioro et al., 2014; Marois, Carrou, Kobisch, 
& Gautier‐Bouchardon, 2007) or detected by PCR (Woolley et al., 
2012) in the liver, spleen and kidneys of experimentally infected and 
contact pigs. However, this spread within the body appears to be 
transient and is likely not involved in the development of the dis‐
ease (Marois et al., 2007; Woolley et al., 2012). Woolley et al. (2012) 
could only detect the highly virulent isolate in internal organs and 
not the low virulent isolate. Interaction with surface accessible actin 
on the epithelial cells and the causation of cytoskeletal rearrange‐
ments would allow this microorganism to be phagocytosed. It has 
been hypothesized that M. hyopneumoniae can survive within and 
escape the phagolysosome and reside within the cytoplasm (Tacchi 
et al., 2016). Therefore, it could not only evade the immune system 
but could also disseminate to internal organs and persist within the 
host without causing disease. Recent work by Raymond, Turnbull, et 
al. (2018) showed that approximately 8% of M. hyopneumoniae cells 
reside intracellularly, which demonstrates the need to further ex‐
plore this topic.
2.3.2 | Virulence factors
Little is known about the mechanisms involved in these differences 
and the virulence factors of M. hyopneumoniae. It is also unclear why 
in certain pigs, M. hyopneumoniae might remain in the respiratory 
tract without causing clinical signs or which factors are involved in 
progressing from presence of the pathogen to infection. Factors 
contributing to adherence and colonization, as well as the capacity 
to modulate the inflammatory and immune response might play a 
role. Meyns et al. (2007) showed that the difference between the 
highly and low virulent isolates was associated with a faster in vitro 
growth, a higher capacity to multiply in the lungs and the induc‐
tion of a more severe inflammation process (e.g. higher TNF‐alpha 
and IL‐1β concentration in BAL fluid) by the highly virulent isolate. 
Woolley et al. (2012) also detected significantly higher levels of IL‐1β 
and IL‐6 in BAL fluid in pigs challenged with a highly virulent strain. 
A faster in vitro multiplication of a highly virulent isolate during the 
logarithmic phase was confirmed by Calus et al. (2010), suggesting a 
higher capacity to multiply in the lungs. In contrast, Garza‐Moreno 
et al. (2018) described the fastest growing strain to be M. hyopneu‐
moniae strain J using colour changing units. Villarreal et al. (2011) 
demonstrated that contrary to a highly virulent strain, a low virulent 
strain required more than 4 weeks post‐infection to reach maximum 
infection levels and clinical signs.
Different components of the cell membrane (i.e. proteins, gly‐
coproteins and lipoproteins) may serve as adhesins and/or be toxic 
for the respiratory tract cells. Some of the molecules are post‐trans‐
lationally processed and cleaved. It is possible that highly virulent 
strains have a different cell surface composition and/or a different 
proteolytic processing. It has been proposed that a minimum of eight 
repeat region 1 (RR1) units located at the carboxy terminus of the 
mhp183 gene as the cilium‐ and antibody‐binding sites of P97, is re‐
quired for cilium binding (Minion et al., 2000). Whilst the amino acid 
sequence of P97 is highly conserved amongst M. hyopneumoniae 
strains (Wilton, Scarman, Walker, & Djordjevic, 1998), the number 
of tandem 5‐amino acid repeats in RR1 varies considerably between 
isolates, with the M. hyopneumoniae J strain possessing only nine 
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tandem copies in contrast to the fifteen copies present in M. hyo‐
pneumoniae strain 232 (Wilton et al., 1998). However, adherence of 
M. hyopneumoniae to epithelial cilia is a multifactorial process involv‐
ing an array of adhesins including those which lack RR1 and there‐
fore the number of repeats in RR1 as such may not be suitable as a 
virulence marker.
It has been described that M. hyopneumoniae pathogenic strains 
were able to increase intracellular calcium concentrations in porcine 
ciliated epithelial cells. However, such increase was not observed in 
non‐pathogenic M. hyopneumoniae and M. flocculare strains (Park et 
al., 2002). Additionally, M. hyopneumoniae strains characterized as 
highly virulent were able to induce higher cytoplasmic calcium con‐
centrations in neutrophils, compared to low virulent ones, suggest‐
ing that signal transduction mechanisms in neutrophils are altered by 
virulent M. hyopneumoniae strains (Chen et al., 1992).
Mycoplasma hyopneumoniae strain passaging in vitro or in vivo 
may alter the virulence quickly. DeBey and Ross (1994) showed 
that after 20–40 in vitro passages compared to only one or two 
passage(s), M. hyopneumoniae strain 232 exhibited a lower capac‐
ity to induce ciliary damage. However, when the same previously 
passaged strain was passaged in gnotobiotic pigs in vivo, the strain 
was reversed to original virulence (DeBey & Ross, 1994). The refer‐
ence strain J, commonly used in commercial vaccines, was originally 
a virulent and pathogenic strain causing mild pneumonia in sows. 
Nevertheless, after continued in vitro passaging, M. hyopneumoniae 
strain J lost its pathogenic capacity to adhere and to cause disease in 
pigs (Zielinski & Ross, 1993).
In addition, a 23 kb region was also observed to be similar to a 
previously described Integrative Conjugal Element (ICE) of M. fer‐
mentans in the genetic material of M. hyopneumoniae strains 7,448 
and 232, that was absent in J strain (Pinto, Chemale, et al., 2007; 
Pinto, Oliveira de Carvalho, et al., 2007). This ICE is generally rec‐
ognized to be involved in virulence in other Mycoplasma species. 
Therefore, the authors suggested that these putative ICE's might 
also be implicated in the virulence of M. hyopneumoniae. Liu et al. 
(2013) not only detected this element in the virulent M. hyopneumo‐
niae strain 168, but also in its attenuated variant. Thus, the role of 
the ICE in the virulence of M. hyopneumoniae remains unclear and 
warrants further research (Maes et al., 2018). Using MLVA testing 
on lungs from slaughtered pigs, Charlebois et al. (2014) showed that 
M. hyopneumoniae strains lacking the detection of Locus 1 protein 
exhibited significantly less severe lesions and lower numbers of bac‐
teria. The gene amplified by this locus encodes for a hypothetical 
protein of 77,078 kDa and the authors suggested that this Locus 1 
protein might be a potential virulence factor for M. hyopneumoniae.
Mycoplasmas in general lack classical virulence factors like tox‐
ins. Nevertheless, the production of a community‐acquired respi‐
ratory distress syndrome toxin was identified for M. pneumoniae, 
which has been shown to potentially contribute to this microorgan‐
ism's pathogenesis (Kannan, Provenzano, Wright, & Baseman, 2005; 
Medina et al., 2012). Therefore, the ability to detect the presence 
of unidentified toxins for other Mycoplasma species may be possi‐
ble in the future. Ferrarini et al. (2018) recently demonstrated that 
pathogenic strains of M. hyopneumoniae are able to use glycerol as a 
carbon source thereby enabling the production of the toxic metab‐
olite hydrogen peroxide. In a previous study, Ferrarini et al. (2016) 
showed that only M. hyopneumoniae, but not the commensal M. 
flocculare, was able to assimilate myo‐inositol and remained viable 
when this was the primary energy source. Therefore, the mecha‐
nisms leading to virulence are complex and more research is needed 
to identify markers for virulence (Maes et al., 2018).
2.3.3 | Effect of the number of different strains 
on the severity of lung lesions
Several M. hyopneumoniae strains can be detected in a herd and 
even in one individual pig from bronchoalveolar lavage fluid or lung 
tissue (Michiels et al., 2017; Nathues, Grosse Beilage, Kreienbrock, 
Rosengarten, & Spergser, 2011; Dos Santos et al., 2015; Vranckx et 
al., 2011). Although some studies point in the direction that co‐infec‐
tion with more than one strain in a pig or batch of pigs might result in 
more severe lung lesions (Michiels et al., 2017; Villarreal et al., 2009; 
Vranckx et al., 2011), other studies did not detect such a relation‐
ship (Charlebois et al., 2014). Michiels et al. (2017) investigated the 
genetic diversity of M. hyopneumoniae strains in different succes‐
sive batches of 10 pig herds using Multiple‐Locus Variable number 
tandem repeat Analysis (MLVA). Multivariable analyses accounting 
for the potential effect of risk factors for respiratory disease were 
performed to assess associations between the number of differ‐
ent Variable Number Tandem Repeats (VNTR) variants per batch 
and lung lesions as outcome variables. Batches of slaughtered pigs 
with several M. hyopneumoniae strains showed a significantly higher 
prevalence and severity of Mycoplasma‐like lung lesions at slaughter, 
implying that reducing the number of different strains may lead to 
less lung lesions at slaughter. The exact mechanisms leading to this 
phenomenon remain to be elucidated.
2.3.4 | Acquired antimicrobial resistance
Antimicrobial susceptibility testing of M. hyopneumoniae is not 
routinely performed due to the fastidious isolation of the patho‐
gen. In addition, established breakpoints are lacking for result in‐
terpretation and for identifying strains as sensitive or resistant. 
Mycoplasma hyopneumoniae is intrinsically resistant to antibiotics 
which interfere with the polymerization of cell wall precursors, 
such as beta‐lactam antibiotics and to polymyxins, 14‐mem‐
bered ring macrolides (such as oleandomycin and erythromycin), 
trimethoprim and sulfonamides. In vitro, acquired resistance has 
been documented for tetracyclines, 15‐membered ring macrolides 
(tulathromycin, gamithromycin), 16‐membered ring macrolides (ty‐
losin, tilmicosin), lincosamides (lincomycin) and fluoroquinolones 
(Felde, Kreizinger, Sulyok, Hrivnak, et al., 2018; Felde, Kreizinger, 
Sulyok, Marton, et al., 2018; Klein et al., 2017; Tavio, Poveda, 
Assunção, Ramírez, & Poveda, 2014; Vicca et al., 2007; Vicca et 
al., 2004). It was shown that mutations in the 23S rRNA gene 
were responsible for resistance to macrolides and lincosamides 
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(Stakenborg et al., 2005). Isolates that were resistant against qui‐
nolones harboured mutations in the quinolone resistance‐deter‐
mining regions (QRDR) of gyrA, gyrB, parC or parE. In four out of 
five resistant isolates, there was only one‐point mutation (C → A) 
in parC, resulting in an amino acid change from serine to tyrosine 
at position 80 (E. coli numbering). These isolates showed a mini‐
mum inhibitory concentration (MIC) of enrofloxacin of 0.5 μg/ml, 
while for sensitive isolates the MIC of enrofloxacin was ≤0.06 μg/
ml. One resistant isolate had an extra mutation (C → T) in gyrA 
resulting in an amino acid change from alanine to valine at position 
83 (E. coli numbering), correlated with an increase in the MIC of 
enrofloxacin (>1 μg/ml). Felde, Kreizinger, Sulyok, Marton, et al. 
(2018) and Felde, Kreizinger, Sulyok, Hrivnak, et al. (2018) showed 
that single nucleotide polymorphisms in parC correlated with a 
decrease in fluoroquinolone susceptibility. No mutations result‐
ing in an amino acid change were detected in the QRDR of the 
gyrB and parE genes of the selected isolates (Thongkamkoon et 
al., 2013; Felde, Kreizinger, Sulyok, Marton, et al., 2018; Felde, 
Kreizinger, Sulyok, Hrivnak, et al., 2018). As summarized by 
Gautier‐Bourchardon (2018), M. hyopneumoniae strains isolated 
from 2000 to 2016 showed higher in vitro MIC levels for tetracy‐
clines, macrolides, lincosamides and fluoroquinolones compared 
to those isolated prior to 2000.
2.4 | Genomic variability
Through the employment of several molecular techniques, genomic 
variation has been evident in several M. hyopneumoniae strains and 
isolates at different geographic and population levels (Table 2). The 
M. hyopneumoniae genome has been fully sequenced for six strains 
and has been described to be composed of 892,758–964,503 base 
pairs and contains a low G + C content of 28.4%–28.6% (Minion et 
al., 2004; Vasconcelos et al., 2005; Liu et al., 2011; Siqueira et al., 
2013; Han et al., 2017). In addition, 679–692 predicted protein cod‐
ing sequences have been described, in which approximately 44%, 
38% and 12% encode for hypothetically functional, conserved and 
unique proteins respectively (Minion et al., 2004; Vasconcelos et 
al., 2005; Liu et al., 2011; Siqueira et al., 2013; Han et al., 2017). 
Like other mycoplasmas, M. hyopneumoniae has the ability to modify 
gene and antigenic expression, which primarily occurs during DNA 
replication (Minion et al., 2004). Within many lipoprotein and ad‐
hesion encoding genes, tandem repetitive regions of DNA, known 
as VNTRs are present and undergo phase variation, recombination 
and slipped strand mispairing during replication, thus resulting in ad‐
herence and antigenic variation from modifications in cell surface 
structure (Razin et al., 1998; Rosengarten et al., 2000; Minion et al., 
2000; de Castro et al., 2006). Differences in VNTR length of several 
adhesins and chromosomal restriction patterns have been described 
across M. hyopneumoniae strains and isolates using complete or indi‐
vidual gene sequencing (Garza‐Moreno et al., 2019; Hsu & Minion, 
1998; Vasconcelos et al., 2005), field inversion gel electrophoresis 
(Frey, Haldimann, & Nicolet, 1992) and random amplified polymor‐
phism DNA analysis (Artiushin & Minion, 1996).
From a geographical standpoint, increased genomic heteroge‐
neity has been demonstrated across M. hyopneumoniae isolates and 
strains originating from diverse regions (i.e. different countries) com‐
pared to those originating from a more localized region (Frey et al., 
1992; Dos Santos et al., 2015). The identification of potential drivers 
(e.g. temporal changes) for M. hyopneumoniae genomic heterogene‐
ity across different geographical locations has not been investigated. 
Several M. hyopneumoniae VNTR types have been identified (Vranckx 
et al., 2011) within a country and individual state, suggesting a wide 
circulation of M. hyopneumoniae VNTR types in swine populations 
(Dos Santos et al., 2015; Takeuti, Barcellos, Andrade, Almeida, & 
Pieters, 2017; Vranckx et al., 2011). Among all VNTR types detected 
in different countries (i.e. United States, Mexico, Brazil and Spain), a 
common M. hyopneumoniae VNTR type has not been detected (Dos 
Santos et al., 2015). In comparison, a similar circulation of VNTR 
types for M. pneumoniae has been shown across different countries 
(Dégrange et al., 2009). Furthermore, in swine dense geographical 
areas, multiple M. hyopneumoniae VNTR types have been identified 
in endemically infected herds and even in individual pigs (Michiels 
et al., 2017; Nathues et al., 2011; Vranckx et al., 2011). Greater ho‐
mogeneity and/or identical M. hyopneumoniae VNTR types in herds 
that are of close geographical proximity or herds that belong to the 
same production flow, have also been shown (Charlebois et al., 2014; 
Mayor, Zeeh, Frey, & Kuhnert, 2007; Pantoja, Pettit, Santos, Tubbs, & 
Pieters, 2016; Rebaque et al., 2018; Takeuti et al., 2017). In all cases, 
one distinct M. hyopneumoniae VNTR type along with multiple clonal 
types (i.e. similar VNTR types) has been described. It could be hy‐
pothesized that the degree of M. hyopneumoniae genetic variability 
among herds might be influenced by herd management. However, 
the potential drivers and mechanisms of such heterogeneity have 
been poorly explored and defined.
3  | MOLECUL AR CHAR AC TERIZ ATION 
METHODS OF MYCOPL A SMA S
3.1 | Mycoplasma spp.
With the advancement of molecular technology and more compre‐
hensive knowledge of mycoplasmas, the repertoire of molecular di‐
agnostics and characterization methods have expanded from nucleic 
acid amplification to the identification of single nucleotide polymor‐
phism and variation in VNTR and house‐keeping gene length and 
composition (Diaz & Winchell, 2016). The employment of sequenc‐
ing and typing methods have allowed for a higher level of discrimina‐
tion among strains and isolates to further understand Mycoplasma 
spp. epidemiology and pathogenesis (Diaz & Winchell, 2016).
3.2 | Mycoplasma hyopneumoniae
Several techniques have been standardized to characterize M. hyo‐
pneumoniae using nucleic acid amplification, including Amplified 
Fragment Length Polymorphism (AFLP; Kokotovic, Friis, Jensen, 
& Ahrens, 1999; Stakenborg et al., 2006), Restriction Amplified 
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Polymorphic DNA analysis (RAPD; Artiushin & Minion, 1996; Vicca 
et al., 2003), Pulse‐Field Gel Electrophoresis (PFGE; Stakenborg 
et al., 2006), Random Fragment Length Polymorphism (RFLP; 
Stakenborg et al., 2006) and DNA Microarrays (Madsen et al., 2007). 
However, variations in reproducibility, feasibility and discriminatory 
power exist among these molecular methods (Sibila et al., 2009; 
TA B L E  2   Summary of literature assessing Mycoplasma hyopneumoniae genomic diversity across different population levels
Target
Molecular 
technique Samples type Summary of findings Reference
Geographic ApaI FIGE M. hyopneumoniae 
reference strains 
and field isolates
Increased heterogeneity in restric‐
tion patterns among isolates 
originating from diverse geographi‐
cal regions
Frey et al. 
(1992)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684)
MLVA M. hyopneumoniae 
clinical samples
High genetic variability within and 
across countries
No common VNTR type across 
countries
Dos Santos et 
al. (2015)
Production flow P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H4
MLVA M. hyopneumoniae 
clinical samples
Minimal genetic variability across 
a production flow over time. 
Presence of a dominant VNTR type 
with clonal types
Rebaque et al. 
(2018)
Herd P97 (RR1, RR2; mhp 
138)
P146 (mhp 684)
RAPD
AFLP
RFLP‐P146 
RFLP‐P97
M. hyopneumoniae 
reference strains 
and field isolates
Isolates (60%) originating from the 
same herd had identical RFLP‐
P146 profiles
Multiple isolates in three herds 
were indistinguishable among all 
techniques
Two isolates were detected in dif‐
ferent geographical locations
Stakenborg et 
al. (2006)
P146 (mhp 684) Gene 
sequence
M. hyopneumoniae 
reference strains, 
field isolates and 
clinical samples
Eight different clusters were 
observed in 11 farms. Farms in 
the same cluster were of close 
proximity
Farms of multi‐site productions 
shared an identical cluster
Farms of close geographical or 
operational proximity had identical 
or closely related strains
Mayor et al. 
(2007)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H4
RAPD M. hyopneumoniae 
field isolates
Isolate similarity (<80%) across four 
farms
Clusters (≤2) of isolates recovered 
from the same herd and individual 
pig
High genetic heterogeneity across 
individual pigs, within and across 
different pig herds
Nathues et al. 
(2011)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H4
MLVA M. hyopneumoniae 
clinical samples
One dominant VNTR type and 2–3 
types of clonal variance were 
present within a herd
Vranckx et al. 
(2011)
P97 RR1, RR2 
(mhp 138) 
Locus 1,2 
P146
MLVA 
RFLP‐P146
M. hyopneumoniae 
isolates and clini‐
cal samples
No association between virulence 
and cluster
High diversity with greater homoge‐
neity in the same herd
Field isolates (45%) demonstrated 
<55% homology with vaccinal and 
reference strains
Charlebois et 
al. (2014)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H4 
H5 
P95
MLVA M. hyopneumoniae 
clinical samples
Different VNTR types were identi‐
fied among and within herds and 
among bacterin strains
Tamiozzo et al. 
(2015)
(Continues)
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Stakenborg et al., 2006). To provide further discrimination, Multiple‐
Locus Sequence Typing (MLST; Mayor, Jores, Korczak, & Kuhnert, 
2008), MLVA (Nathues et al., 2011; Dos Santos et al., 2015; Tamiozzo 
et al., 2015; Vranckx et al., 2011), partial‐gene sequencing (Garza‐
Moreno et al., 2019; Mayor et al., 2007; Tsungda & Minion, 1998) 
and complete genome sequencing (Minion et al., 2004; Vasconcelos 
et al., 2005; Liu et al., 2011; Siqueira et al., 2013; Han et al., 2017) 
have been recently employed. While each molecular method has its 
strengths and disadvantages, it is important to consider the question 
at hand, resources available and capabilities that each method can 
provide prior to the utilization of such techniques.
Thus far, the utilization of molecular characterization methods 
for M. hyopneumoniae has been commonly employed in research set‐
tings. However, the application of M. hyopneumoniae genomic char‐
acterization in field investigations has increased in the United States 
to provide veterinarians additional insight related to the transmis‐
sion and control of this microorganism. Although complete genome 
sequencing has been proposed as a highly descriptive and thorough 
method, the routine application of this technique may represent a 
more futuristic approach based on its current practicality and feasi‐
bility as it applies to disease investigations. Therefore, the utilization 
of typing methods (i.e. MLVA), complete or partial‐gene sequencing 
for M. hyopneumoniae characterization has increased in veterinary 
diagnostic laboratories as the control and elimination of this micro‐
organism is widely attempted worldwide (Maes et al., 2018).
3.2.1 | Mycoplasma hyopneumoniae typing methods
The most commonly employed genomic typing methods for M. hyo‐
pneumoniae are MLST and MLVA. The MLST assay has been utilized 
Target
Molecular 
technique Samples type Summary of findings Reference
P97 RR1 (mhp 138)
P146 RR3 (mhp 684)
MLVA M. hyopneumoniae 
clinical samples
Four unique VNTR types were iden‐
tified across three farms
All farms shared a similar type
Pantoja et al. 
(2016)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684)
MLVA M. hyopneumoniae 
clinical samples
Unique VNTR types (17) were iden‐
tified across three farms
Multiple VNTR types (<11) detected 
per farm
Takeuti et al. 
(2017)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H5 RR2 
H1
MLVA M. hyopneumoniae 
clinical samples
Multiple VNTR types (<13) identi‐
fied per batch
Prevalence and severity of pneu‐
monia lesions at slaughter were 
significantly higher in batches that 
contained multiple VNTR types
Michiels et al. 
(2017)
Individual P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H5 RR2 
H1
MLVA M. hyopneumoniae 
clinical samples
Multiple VNTR types (2–3) present 
in a lung
Michiels et al. 
(2017)
P97 RR1, RR2 (mhp 
138)
P146 RR3 (mhp 684) 
7 housekeeping genes
MLVA 
MLST 
Gene 
sequence
M. hyopneumoniae 
field isolates
High variability was detected by the 
three used methods
Characterization of P146 can refine 
closer genetic relationships among 
VNTR types
Felde, 
Kreizinger, 
Sulyok, 
Marton, et 
al. (2018) 
and Felde, 
Kreizinger, 
Sulyok, 
Hrivnak, et al. 
(2018)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684) 
H5 RR2 
H1
Gene 
sequence
M. hyopneumoniae 
clinical samples 
Five commercial 
vaccines
One to three VNTR types detected 
per farm
Different VNTR types were de‐
tected in vaccinated and vacci‐
nated farms
VNTR types detected in vaccinated 
farms were different from those 
found in commercial vaccines
Garza‐Moreno 
et al. (2019)
Note: The first column denotes the level (from the individual animal to region) in which Mycoplasma hyopneumoniae diversity has been evaluated.
Abbreviations: AFLP: Amplified Fragment Length Polymorphism; FIGE: Field inversion gel electrophoresis; Mhp: Mycoplasma hyopneumoniae; MLVA: 
Multiple‐Locus Variable tandem repeat Analysis; RAPD: Random Amplified Polymorphic DNA; RFLP: Restriction Fragment Length Polymorphism; 
RR: Repeat Region; VNTR: Variable Number Tandem Repeat.
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for many bacterial species and was standardized for the molecu‐
lar characterization of M. hyopneumoniae by Mayor et al. (2008). 
Several loci have been targeted, including putative and house‐
keeping genes (i.e. efp, metG, pgiB, recA, adk, rpoB, tpiA, gyrB and 
gmk). As identified in Mycoplasma spp., house‐keeping genes have 
been described to be highly conserved, resulting in limited variation 
among strains (Dumke, Catrein, Pirkil, Herrmann, & Jacobs, 2003). 
The MLVA assay is a typing method that identifies the number of 
VNTRs within surface proteins and has been employed for the mo‐
lecular characterization of M. hyopneumoniae in Spain, Argentina, 
Belgium, United States, Mexico and Brazil (Table 3; de Castro et 
al., 2006; Michiels et al., 2017; Dos Santos et al., 2015; Takeuti et 
al., 2017; Tamiozzo et al., 2015; Vranckx et al., 2011). Several tech‐
niques have described the M. hyopneumoniae variability using dif‐
ferent loci numbers (e.g. 2–4) and types (i.e. P97, P146, H1, H4, H5; 
Table 3). The targeted loci have been selected for their presumed 
bacterial adhesive capability to ciliated epithelium, presence of re‐
petitive tandem repeats, or high degree of variability (Rebaque et 
al., 2018; Dos Santos et al., 2015; Tamiozzo et al., 2015; Vranckx et 
al., 2011). Currently, the MLVA assay is commonly performed due 
to its high discriminatory power, reproducibility and use of clinical 
samples has been widely implemented for epidemiological inves‐
tigations (Dos Santos et al., 2015; Vranckx et al., 2011). Despite 
this, current discrepancies regarding the genomic characterization 
of M. hyopneumoniae and interpretation currently exist. Like other 
typing methods, MLVA evaluates few genomic areas. Therefore, 
other areas within the genome that may influence variability may 
be unrepresented.
3.2.2 | Mycoplasma hyopneumoniae 
sequencing methods
Genomic sequencing methods have been developed to evaluate the 
entire genome or individual genes of M. hyopneumoniae. To further 
explore how the genomic structure of M. hyopneumoniae can influ‐
ence pathogenesis and host‐pathogen interaction, complete genome 
sequencing has been attempted (Minion et al., 2004; Vasconcelos 
et al., 2005; Liu et al., 2011; Siqueira et al., 2013; Han et al., 2017). 
While this molecular technique offers descriptive and thorough 
information, the feasibility to routinely perform complete genome 
sequencing may be limited due to cost, difficulty of interpreta‐
tion, computational requirements and the need for sophisticated 
equipment. Therefore, complete or partial sequencing of individual 
M. hyopneumoniae genes has been attempted for the purpose of 
strain typing (Felde, Kreizinger, Sulyok, Hrivnak, et al., 2018; Felde, 
Kreizinger, Sulyok, Marton, et al., 2018; Mayor et al., 2007). Due to 
the paralogous nature of P146 with P97 and the presence of distinct 
motifs and consensus regions (i.e. PQ, S, PS for locus P146), partial 
sequencing of the encoded gene Mhp‐684 (3,954 bp) has been previ‐
ously described (Bogema et al., 2012; Mayor et al., 2007). With the 
employment of sequencing methods, the number of VNTRs have 
also been evaluated for M. hyopneumoniae (Felde, Kreizinger, Sulyok, 
TA B L E  3   Standardized Mycoplasma hyopneumoniae Multiple‐Locus Variable number tandem repeat Analysis assays (MLVA)
Target (gene) Consensus region Primers (forward; reverse; 5′−3′) Reference
P97 RR1 (mhp 138)
P146 RR3 (mhp 684
H5 RR2 (mhp 447) 
H1 (mhp 037)
AAKPE(V) 
S 
Q
QTTQ(KD)
6‐FAM‐CATTTGAAGCTATCAAAAAAGGGGAAACTA; 
GTCAGTATATTCTAATTTATAACTAAAAGCCATTG
HEX‐ACTCCAAGACGAAGATCTTGACTATCAAAT; 
CCGATATTAGAACTTGCAAGATAAAGC
AATCTCAGTACAAAAAATCAAGAAAACTCC; PET‐
TGTTTTTTAAGCTGTTCTTCGGGTAC 
NED‐GCTACTGTTTATTTCCAATTTGATG; 
GACAAAGACAAATTTTGTAGTTTGG
Vranckx et al. 
(2011)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684 
H4 
H5 
P95
AAKPE(V) 
S
QTTQ(KD) 
Q 
QEK
AGCATTTTTTCCTTAAAGCAG; TTGATCTGTTGAACCTGAGG
AAAACCCAAAGTAGTGATTC; TGTATCGTTTCAGAAGAAG 
TCGGGATTTTTTCTCTTTCTTC; AGGATCTTGTGGTTTTAGCG
AAGTAAAAAAGACCTCGAAG; CCAAAGAATTAATCCAAGTC 
ATTTATCCTTTACTTAGCGG; AAGACAAGTGGATATTTTGC
Tamiozzo et al. 
(2015), modi‐
fied from de 
Castro et al. 
(2006)
P97 RR1 (mhp 138)
P146 RR3 (mhp 684)
AAKPE(V) 
S
6‐FAM‐CATTTGAAGCTATCAAAAAAGGGGAAACTA; 
GTCAGTATATTCTAATTTATAACTAAAAGCCATTG
HEX‐ACTCCAAGACGAAGATCTTGACTATCAAAT; 
CCGATATTAGAACTTGCAAGATAAAGC
Dos Santos 
et al. (2015), 
modified 
from Vranckx 
et al. (2011)
P7 RR1 (mhp 138)
P146 RR3 (mhp 684 
H4
AAKPE(V) 
S
QTTQ(KD)
6‐FAM‐CATTTGAAGCTATCAAAAAAGGGGAAACTA; 
GTCAGTATATTCTAATTTATAACTAAAAGCCATTG
HEX‐ACTCCAAGACGAAGATCTTGACTATCAAAT; 
CCGATATTAGAACTTGCAAGATAAAGC 
TCGGGATTTTTTCTCTTTCTTC; AGGATCTTGTGGTTTTAGCG
Rebaque et al. 
(2018), modi‐
fied from 
Vranckx et 
al. (2011), de 
Castro et al. 
(2006)
Note: Abbreviations: Mhp: Mycoplasma hyopneumoniae; RR: Repeat Region.
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Hrivnak, et al., 2018; Felde, Kreizinger, Sulyok, Marton, et al., 2018; 
Garza‐Moreno et al., 2019). However, as well with MLVA, there is 
limited knowledge on the interpretation of sequencing methods and 
the insight gained from the comparison of molecular assays that 
evaluate nucleotide differences at the consensus or individual gene 
level. To provide further understanding, a comprehensive review of 
the M. hyopneumoniae genome is necessary to identify regions that 
can be utilized for classification, as well as for prevention and control 
efforts.
4  | PROPOSED TERMINOLOGY FOR THE 
STUDY OF  MYCOPL A SMA HYOPN EUMON IAE  
GENOMIC VARIABILIT Y
To provide clarity on disease investigations, defining a common‐
ality for M. hyopneumoniae genomic classification using MLVA is 
proposed based on current knowledge. One of the reasons why a 
genomic classification criterion for M. hyopneumoniae has not been 
previously established for MLVA is due to the fact that the agree‐
ment of a common technique and terminology has not been made. 
However, a systematic and scientific approach to genetically classify 
M. hyopneumoniae should be made in congruency to help promote 
and drive scientific knowledge advancement on this microorganism.
Across the literature, different terms such as strains, variants, 
types and typing profiles have been used to define M. hyopneumo‐
niae strains according to the VNTRs obtained by different typing or 
sequencing methods. In this review, the term ‘VNTR types’ is sug‐
gested since the terminology ‘strain’ is often defined as a pathogen 
that has been isolated and characterized and a ‘variant’ refers to any 
genomic modification of a pathogen. In addition, the term ‘VNTR 
types’ is proposed as it can be incorporated for MLVA and sequenc‐
ing assays that are employed to evaluate the number of VNTRs 
within specific loci.
Classification of determining a unique or different M. hyopneu‐
moniae VNTR type compared to other types varies and continues to 
be arbitrary. Such variation across several MLVA techniques may be 
due to differences in the type and number of loci targeted as well as 
analytic method. For example, one method for classifying a unique 
M. hyopneumoniae VNTR type may be based on one tandem repeat 
difference in surface adhesin proteins (e.g. 16–17 to 17–17). In com‐
parison, this minute difference in VNTR length might be perceived 
from a genomic modification, probably without biological signifi‐
cance and related to host‐pathogen adaptations during evolutional 
pressures. Currently, the biological importance of variations in VNTR 
length and translation of repeat motifs remains unclear. Due to these 
reasons, the ability to make inferences from previously published 
literature to understand the genomic variability of M. hyopneumo‐
niae becomes challenging, especially when different techniques are 
employed. Therefore, it is proposed that a minimum of two loci (i.e. 
P97 and P146) should be included in published literature papers. On 
the other hand, minimum spanning trees and unweighted pair group 
method with arithmetic mean (UPGMA) dendrograms have been 
employed to illustrate differences between VNTR types; however, 
the relationship and/or difference among types is not easily por‐
trayed as each locus is unequally weighted. Therefore, the need to 
identify a bioinformatics tool that can portray differences between 
VNTR types in a systematic and numerical manner is highlighted. 
Furthermore, there is a need to create a database of M. hyopneu‐
moniae VNTR types worldwide, with a curator and free access. In 
doing so, this knowledge can be applied towards the development of 
a genomic classification method for M. hyopneumoniae.
5  | CONCLUSIONS
Mycoplasma hyopneumoniae variation across several strains and field 
isolates has been described at the antigenic, proteomic, transcrip‐
tomic, pathogenic and genomic levels. This microorganism may un‐
dergo adaptations that may drive variation and differences between 
host‐pathogen interactions. One approach to provide further insight 
on this topic is the molecular characterization of M. hyopneumoniae 
using genomic sequencing and typing methods, which has been com‐
monly implemented in research and clinical investigations. However, 
the agreement of a shared terminology and classification for the var‐
ious techniques, specifically MLVA, has not been described and thus 
causes discrepancies and the inability to make inferences across the 
literature. Therefore, current molecular trends for M. hyopneumo‐
niae have been outlined and common terminology and classification 
based on VNTR types have been proposed.
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